Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
20
Number of overlapping holdings
31.7%
% of RSPH's 63 holdings also in WDNA
22.5%
% of WDNA's 91 holdings also in RSPH
Overlap by Weight
Sector Drift (RSPH minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in RSPH |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 1.6% | 1.9% | 1.6% |
|
VERTEX PHARMACEUTICALS INC | 1.6% | 1.3% | 1.3% |
|
CATALENT INC | 1.6% | 1.3% | 1.3% |
|
DANAHER CORP | 1.6% | 1.3% | 1.3% |
|
REGENERON PHARMACEUTICALS | 1.6% | 1.2% | 1.2% |
Position Highlights (Non-Overlapping Exposures)
RSPH Overweight Relative to WDNA
|
ELEVANCE HEALTH INC | 1.8% |
|
UNITEDHEALTH GROUP INC | 1.8% |
|
WEST PHARMACEUTICAL SERVICES | 1.7% |
|
CIGNA CORPORATION | 1.7% |
|
QUEST DIAGNOSTICS | 1.7% |
|
AMERISOURCEBERGEN CORP | 1.7% |
|
MCKESSON CORP | 1.7% |
|
BOSTON SCIENTIFIC CORP | 1.7% |
|
HOLOGIC INC | 1.6% |
|
BECTON DICKINSON AND CO | 1.6% |
RSPH Underweight Relative to WDNA
|
IOVANCE BIOTHERAPEUTICS INC | -3.9% |
|
TWIST BIOSCIENCE CORP. | -3.4% |
|
FATE THERAPEUTICS INC | -3.1% |
 |
NOVOZYMES A/S-B SHARES | -2.4% |
|
BLUEPRINT MEDICINES CORP. | -2.2% |
|
BRIDGEBIO PHARMA, INC. | -2.0% |
|
NATERA INC | -1.9% |
|
CRISPR THERAPEUTICS AG | -1.8% |
 |
ALCOBRA LTD | -1.7% |
|
VERICEL CORPORATION | -1.7% |